Yüklüyor......
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Since the approval in 2017 and the outstanding success of Kymriah® and Yescarta®, the number of clinical trials investigating the safety and efficacy of chimeric antigen receptor-modified autologous T cells has been constantly rising. Currently, more than 200 clinical trials are listed on clinicaltr...
Kaydedildi:
| Yayımlandı: | Transfus Med Hemother |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558329/ https://ncbi.nlm.nih.gov/pubmed/31244577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495771 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|